{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:15:05Z","timestamp":1790082905921,"version":"4.0.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["444089\/2023-3"],"award-info":[{"award-number":["444089\/2023-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["401692\/2023-0"],"award-info":[{"award-number":["401692\/2023-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301069\/2018-2"],"award-info":[{"award-number":["301069\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["440852\/2023-4"],"award-info":[{"award-number":["440852\/2023-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/010.000981\/2019"],"award-info":[{"award-number":["E-26\/010.000981\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/200.815\/2021"],"award-info":[{"award-number":["E-26\/200.815\/2021"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119869","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:00:45Z","timestamp":1787677245000},"page":"119869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Radiolabeled drug-delivery and controlled-release nanocarriers for arthritis: Clinical evidence, kinetic modeling, radiation-safety challenges, and precision nanotheranostics"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-054X","authenticated-orcid":false,"given":"Tais Magne","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Magalhaes Rebelo","family":"Alencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Medeiros","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre B.A.","family":"Fechine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ricci-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Qaiser","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-481X","authenticated-orcid":false,"given":"Ralph","family":"Santos-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119869_bib1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.biopha.2026.119869_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2026.119869_bib3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/jor.22630","article-title":"Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra-articular injected avidin in rat knee joints","volume":"32","author":"Bajpayee","year":"2014","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.biopha.2026.119869_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.joca.2015.07.010","article-title":"Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term","volume":"24","author":"Bajpayee","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.biopha.2026.119869_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2019.12.020","article-title":"Multi-arm Avidin nano-construct for intra-cartilage delivery of small molecule drugs","volume":"318","author":"He","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119869_bib6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2106\/JBJS.17.00154","article-title":"Effects of a single intra-articular injection of a microsphere formulation of triamcinolone acetonide on knee osteoarthritis pain: a double-blinded, randomized, placebo-controlled, multinational study","volume":"100","author":"Conaghan","year":"2018","journal-title":"J. Bone Jt. Surg. Am."},{"key":"10.1016\/j.biopha.2026.119869_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2022.100268","article-title":"The effect of intra-articular extended-release triamcinolone acetonide on OARSI-recommended physical performance measures in adults with bilateral symptomatic knee osteoarthritis","volume":"4","author":"Segal","year":"2022","journal-title":"Osteoarthr. Cartil. Open."},{"key":"10.1016\/j.biopha.2026.119869_bib8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2967\/jnumed.123.267297","article-title":"Safety and efficacy of radiosynoviorthesis: a prospective canadian multicenter study","volume":"65","author":"Desaulniers","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.biopha.2026.119869_bib9","first-page":"7475","article-title":"Radiosynovectomy for the treatment of chronic hemophilic synovitis: an old technique, but still very effective","volume":"11","author":"Rodriguez-Merchan","year":"2022","journal-title":"J. Clin. Med. 2022"},{"key":"10.1016\/j.biopha.2026.119869_bib10","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1039\/D2NA00229A","article-title":"Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment","volume":"4","author":"Nasra","year":"2022","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.biopha.2026.119869_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2024.06.010","article-title":"Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment","volume":"371","author":"Deng","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119869_bib12","doi-asserted-by":"crossref","first-page":"14253","DOI":"10.2147\/IJN.S553826","article-title":"Recent advances in biomimetic drug delivery for rheumatoid arthritis treatment","volume":"20","author":"Xiang","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119869_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119869_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1039\/D4NR03611E","article-title":"Revolutionizing rheumatoid arthritis treatment with emerging cutaneous drug delivery systems: overcoming the challenges and paving the way forward","volume":"17","author":"Priya","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2026.119869_bib15","doi-asserted-by":"crossref","first-page":"S685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2026.119869_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.biopha.2026.119869_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/annrheumdis-2021-220973","article-title":"EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis","volume":"81","author":"Nagy","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2026.119869_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2026.119869_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrrheum.2016.210","article-title":"Cartilage-targeting drug delivery: can electrostatic interactions help?","volume":"13","author":"Bajpayee","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2026.119869_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11095-012-0870-x","article-title":"Nanoparticles for improved local retention after intra-articular injection into the knee joint","volume":"30","author":"Morgen","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2026.119869_bib21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biomaterials.2013.09.091","article-title":"Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis","volume":"35","author":"Bajpayee","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119869_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119869_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128513","article-title":"Protein corona, influence on drug delivery system and its improvement strategy: a review","volume":"256","author":"Guo","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2026.119869_bib25","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/D2LC00799A","article-title":"Nanoparticle protein corona: from structure and function to therapeutic targeting","volume":"23","author":"Bashiri","year":"2023","journal-title":"Lab. Chip"},{"key":"10.1016\/j.biopha.2026.119869_bib26","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biopha.2026.119869_bib27","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","article-title":"Nanomedicine(s) under the microscope","volume":"8","author":"Duncan","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2026.119869_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0169-409X(95)00039-A","article-title":"Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system","volume":"17","author":"Storm","year":"1995","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119869_bib32","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1073\/pnas.0608582104","article-title":"Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles","volume":"104","author":"Cedervall","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119869_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103046","article-title":"Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery","volume":"85","author":"Chou","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119869_bib34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/wnan.157","article-title":"Nanotherapeutic approaches for the treatment of rheumatoid arthritis","volume":"3","author":"Pham","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119869_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semarthrit.2008.08.004","article-title":"The potential of liposomal drug delivery for the treatment of inflammatory arthritis","volume":"39","author":"Vanniasinghe","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2026.119869_bib36","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.addr.2012.03.006","article-title":"Development of macromolecular prodrug for rheumatoid arthritis","volume":"64","author":"Yuan","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib37","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1039\/C7BM00254H","article-title":"Recent advances in nanomedicines for the treatment of rheumatoid arthritis","volume":"5","author":"Wang","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119869_bib38","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/art.21719","article-title":"Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis","volume":"54","author":"Koning","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2026.119869_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054016","article-title":"Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation","volume":"8","author":"Hofkens","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119869_bib40","article-title":"Nanocrystal-polymer particles: extended delivery carriers for osteoarthritis treatment","volume":"14","author":"Maudens","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.biopha.2026.119869_bib41","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/10717544.2022.2048130","article-title":"Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage","volume":"29","author":"Huang","year":"2022","journal-title":"Drug. Deliv."},{"key":"10.1016\/j.biopha.2026.119869_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tvjl.2010.09.019","article-title":"Intra-articular drug delivery: the challenge to extend drug residence time within the joint","volume":"190","author":"Edwards","year":"2011","journal-title":"Vet. J."},{"key":"10.1016\/j.biopha.2026.119869_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrrheum.2013.159","article-title":"Progress in intra-articular therapy","volume":"10","author":"Evans","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2026.119869_bib44","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1039\/D0CS00384K","article-title":"Radiolabelling of nanomaterials for medical imaging and therapy","volume":"50","author":"Pellico","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41181-022-00161-4","article-title":"Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology","volume":"7","author":"Pijeira","year":"2022","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.biopha.2026.119869_bib46","doi-asserted-by":"crossref","first-page":"10907","DOI":"10.1021\/cr500314d","article-title":"Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects","volume":"115","author":"Kunjachan","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/wnan.3","article-title":"Radioactive liposomes","volume":"1","author":"Phillips","year":"2009","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2026.119869_bib48","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1039\/C5TB00677E","article-title":"Radiolanthanide-loaded agglomerated Fe3O4 nanoparticles for possible use in the treatment of arthritis: formulation, characterization and evaluation in rats","volume":"3","author":"Chakraborty","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2026.119869_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119869_bib50","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00259-021-05541-7","article-title":"The EANM guideline for radiosynoviorthesis","volume":"49","author":"Kampen","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.biopha.2026.119869_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/1450-1147.150509","article-title":"Radiosynovectomy in the therapeutic management of arthritis","volume":"14","author":"Knut","year":"2015","journal-title":"World J. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00006231-200207000-00013","article-title":"Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints","volume":"23","author":"Kresnik","year":"2002","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.biopha.2026.119869_bib53","first-page":"130","article-title":"Radiation synovectomy with yttrium-90, rhenium-186 and erbium-169: a systematic literature review with meta-analyses","volume":"27","author":"van der Zant","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biopha.2026.119869_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009749609065647","article-title":"Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy","volume":"25","author":"Clunie","year":"1996","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.biopha.2026.119869_bib55","first-page":"1536","article-title":"Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy","volume":"34","author":"Chinol","year":"1993","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/1450-1147.153908","article-title":"Radiosynovectomy of painful synovitis of knee joints due to rheumatoid arthritis by intra-articular administration of 177Lu-labeled hydroxyapatite particulates: first human study and initial indian experience","volume":"14","author":"Shinto","year":"2015","journal-title":"World J. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5435\/00124635-200401000-00008","article-title":"Advances in radionuclide therapeutics in orthopaedics","volume":"12","author":"Siegel","year":"2004","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.biopha.2026.119869_bib58","article-title":"Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management","volume":"19","author":"Wen","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"13","key":"10.1016\/j.biopha.2026.119869_bib59","first-page":"2166","article-title":"Intra-articular drug delivery for osteoarthritis treatment","volume":"13","author":"Cao","year":"2021","journal-title":"Pharm 2021"},{"key":"10.1016\/j.biopha.2026.119869_bib60","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jconrel.2022.11.018","article-title":"Applications and prospects of intra-articular drug delivery system in arthritis therapeutics","volume":"352","author":"Song","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119869_bib61","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-023-00230-2","article-title":"Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework","volume":"9","author":"Korde","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.biopha.2026.119869_bib62","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jconrel.2022.06.015","article-title":"Assessment of joint pharmacokinetics and consequences for the intraarticular delivery of biologics","volume":"348","author":"Siefen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119869_bib63","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/17425247.2016.1205584","article-title":"Radionuclide imaging of liposomal drug delivery","volume":"13","author":"van der Geest","year":"2016","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.biopha.2026.119869_bib64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.addr.2019.05.012","article-title":"Nuclear imaging of liposomal drug delivery systems: a critical review of radiolabelling methods and applications in nanomedicine","volume":"143","author":"Man","year":"2019","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib65","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.7150\/thno.40403","article-title":"PET imaging of liposomal glucocorticoids using 89Zr-oxine: theranostic applications in inflammatory arthritis","volume":"10","author":"Gawne","year":"2020","journal-title":"Theranostics"},{"issue":"26","key":"10.1016\/j.biopha.2026.119869_bib66","first-page":"5862","article-title":"Common shortcomings in study on radiopharmaceutical design research: a case study of 99mTc-labelled methotrexate","volume":"26","author":"Ko\u00b4zm\u00ed","year":"2021","journal-title":"Mol 2021"},{"key":"10.1016\/j.biopha.2026.119869_bib67","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.addr.2008.04.013","article-title":"Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer","volume":"60","author":"Hamoudeh","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib68","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/ar500362y","article-title":"Positron emission tomography imaging using radiolabeled inorganic nanomaterials","volume":"48","author":"Sun","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2026.119869_bib69","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1039\/D3MH00717K","article-title":"Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results","volume":"10","author":"Filippov","year":"2023","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.biopha.2026.119869_bib70","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano-bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biopha.2026.119869_bib71","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00259-014-2838-z","article-title":"Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals","volume":"41","author":"Decristoforo","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.biopha.2026.119869_bib72","doi-asserted-by":"crossref","first-page":"263S","DOI":"10.2967\/jnumed.120.254532","article-title":"The future of nuclear medicine, molecular imaging, and theranostics","volume":"61","author":"Weber","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib73","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S1470-2045(19)30821-6","article-title":"Radiotheranostics: a roadmap for future development","volume":"21","author":"Herrmann","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119869_bib74","unstructured":"Cyclotron Produced Radionuclides: Principles and Practice (n.d.)."},{"key":"10.1016\/j.biopha.2026.119869_bib75","unstructured":"Radiopharmaceuticals: Production and Availability (n.d.)."},{"issue":"38","key":"10.1016\/j.biopha.2026.119869_bib76","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12149-023-01896-z","article-title":"Role of PET\/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review","volume":"383","author":"Singh","year":"2024","journal-title":"Ann. Nucl. Med. 2024"},{"key":"10.1016\/j.biopha.2026.119869_bib77","article-title":"Metabolic and molecular imaging in inflammatory arthritis","volume":"10","author":"de Sousa","year":"2024","journal-title":"RMD Open."},{"key":"10.1016\/j.biopha.2026.119869_bib78","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acsanm.8b02056","article-title":"Rapid assessment of nanoparticle extravasation in a microfluidic tumor model","volume":"2","author":"Vu","year":"2019","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.biopha.2026.119869_bib79","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s10637-018-0708-4","article-title":"The availability of drug by liposomal drug delivery: individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate","volume":"37","author":"Smits","year":"2019","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.biopha.2026.119869_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109766","article-title":"Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis","volume":"103","author":"Trujillo-Nolasco","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.biopha.2026.119869_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22247","article-title":"99mTc-labeled, tofacitinib citrate encapsulated chitosan microspheres loaded in situ gel formulations for intra-articular treatment of rheumatoid arthritis","volume":"85","author":"Karpuz","year":"2024","journal-title":"Drug. Dev. Res."},{"key":"10.1016\/j.biopha.2026.119869_bib82","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1470-2045(24)00041-X","article-title":"Production and regulatory issues for theranostics","volume":"25","author":"Giammarile","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2026.119869_bib83","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S1470-2045(24)00030-5","article-title":"Recent advances and impending challenges for the radiopharmaceutical sciences in oncology","volume":"25","author":"Lapi","year":"2024","journal-title":"Lancet Oncol."},{"issue":"45","key":"10.1016\/j.biopha.2026.119869_bib84","first-page":"3000","article-title":"Rheumatoid arthritis and reactive oxygen species: a review","volume":"45","author":"Al-Mulla","year":"2023","journal-title":"Curr. Issues Mol. Biol. 2023"},{"key":"10.1016\/j.biopha.2026.119869_bib85","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.sjbs.2021.09.014","article-title":"Exploring the role of cathepsin in rheumatoid arthritis","volume":"29","author":"Behl","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.biopha.2026.119869_bib86","article-title":"Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment","volume":"14","author":"Zhang","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"25","key":"10.1016\/j.biopha.2026.119869_bib87","doi-asserted-by":"crossref","first-page":"11799","DOI":"10.3390\/ijms252111799","article-title":"Controlled stimulus-responsive delivery systems for osteoarthritis treatment","volume":"25","author":"Ye","year":"2024","journal-title":"Int. J. Mol. Sci. 2024"},{"key":"10.1016\/j.biopha.2026.119869_bib88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5114\/reum\/168503","article-title":"Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: a state of the art review","volume":"61","author":"Pulik","year":"2023","journal-title":"Reumatologia"},{"key":"10.1016\/j.biopha.2026.119869_bib89","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.actbio.2023.04.012","article-title":"Glucocorticoid-loaded pH\/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-\u03baB signaling pathway","volume":"164","author":"Lu","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2026.119869_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121018","article-title":"Hyaluronic acid-based M1 macrophage targeting and environmental responsive drug releasing nanoparticle for enhanced treatment of rheumatoid arthritis","volume":"316","author":"Wang","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2026.119869_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212804","article-title":"Matrix metalloproteinase-responsive collagen-oxidized hyaluronic acid injectable hydrogels for osteoarthritic therapy","volume":"137","author":"Yi","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.biopha.2026.119869_bib92","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1039\/D3TB02871B","article-title":"On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis","volume":"12","author":"Roy","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2026.119869_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140823","article-title":"Development of a dual-responsive injectable GelMA\/F127DA hydrogel for enhanced cartilage regeneration in osteoarthritis: Harnessing MMP-triggered and mechanical stress-induced release of therapeutic agents","volume":"304","author":"Sun","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2026.119869_bib94","article-title":"Applications of the ROS-responsive thioketal linker for the production of smart nanomedicines","volume":"14","author":"Rinaldi","year":"2022","journal-title":"Polym. (Basel)"},{"key":"10.1016\/j.biopha.2026.119869_bib95","article-title":"Reactive oxygen species-responsive celastrol-loaded: bilirubin nanoparticles for the treatment of rheumatoid arthritis","volume":"24","author":"Zhao","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.biopha.2026.119869_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1426794","article-title":"Advancements in pH-responsive nanoparticles for osteoarthritis treatment: opportunities and challenges","volume":"12","author":"Liao","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119869_bib97","first-page":"696","article-title":"Responsive hydrogel-based drug delivery platform for osteoarthritis treatment","volume":"10","author":"Yin","year":"2024","journal-title":"Gels 2024"},{"key":"10.1016\/j.biopha.2026.119869_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060770","article-title":"Degradation of drug delivery nanocarriers and payload release: a review of physical methods for tracing nanocarrier biological fate","volume":"13","author":"Perrigue","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119869_bib99","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jconrel.2023.03.025","article-title":"Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions","volume":"356","author":"D\u00edez-Villares","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119869_bib100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.26599\/NBE.2024.9290048","article-title":"Radiolabeled tracing techniques illuminating blood pharmacokinetics in nanomedicine","volume":"16","author":"Zhou","year":"2024","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.biopha.2026.119869_bib101","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00259-016-3415-4","article-title":"The EANM practice guidelines for bone scintigraphy","volume":"43","author":"Van den Wyngaert","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.biopha.2026.119869_bib102","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/41.1.53","article-title":"Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis","volume":"41","author":"Jamar","year":"2002","journal-title":"Rheumatol. (Oxf.)"},{"key":"10.1016\/j.biopha.2026.119869_bib103","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1002\/art.23955","article-title":"Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography","volume":"58","author":"Van Der Laken","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2026.119869_bib104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.30655","article-title":"Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study","volume":"64","author":"Gent","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2026.119869_bib105","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002108","article-title":"Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET","volume":"8","author":"Verweij","year":"2022","journal-title":"RMD Open."},{"key":"10.1016\/j.biopha.2026.119869_bib106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41181-022-00161-4","article-title":"Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology","volume":"7","author":"Pijeira","year":"2022","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.biopha.2026.119869_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.819163","article-title":"Folate receptor beta for macrophage imaging in rheumatoid arthritis","volume":"13","author":"Steinz","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119869_bib108","first-page":"1047","article-title":"First in man study of [18F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis","volume":"10","author":"Verweij","year":"2020","journal-title":"Sci. Rep. 2020 101"},{"key":"10.1016\/j.biopha.2026.119869_bib109","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222052","article-title":"68Ga-FAPI PET\/CT for Rheumatoid Arthritis: A Prospective Study","volume":"307","author":"Luo","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.biopha.2026.119869_bib110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13550-023-01064-4","article-title":"68 Ga]Ga-FAPI-04 PET\/CT may be a predictor for early treatment response in rheumatoid arthritis","volume":"14","author":"Pan","year":"2024","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.biopha.2026.119869_bib111","article-title":"Targeting fibroblast activation protein in rheumatoid arthritis: from molecular imaging to precision therapeutics","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119869_bib112","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","article-title":"Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)","volume":"21","author":"Mori","year":"2024","journal-title":"Npj Imaging 2024"},{"issue":"26","key":"10.1016\/j.biopha.2026.119869_bib113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-023-03258-6","article-title":"Molecular imaging for evaluation of synovitis associated with osteoarthritis: a narrative review","volume":"261","author":"Lee","year":"2024","journal-title":"Arthritis Res. Ther. 2024"},{"key":"10.1016\/j.biopha.2026.119869_bib114","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/ard-2023-224771","article-title":"2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice","volume":"83","author":"Mandl","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2026.119869_bib115","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00256-024-04834-w","article-title":"Recent advances in nuclear medicine and their role in inflammatory arthritis: focus on the emerging role of FAPI PET\/CT","volume":"54","author":"Schmidkonz","year":"2024","journal-title":"Skelet. Radiol."},{"key":"10.1016\/j.biopha.2026.119869_bib116","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119869_bib117","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s11547-019-01014-y","article-title":"Imaging in rheumatoid arthritis: the role of magnetic resonance imaging and computed tomography","volume":"124","author":"\u00d8stergaard","year":"2019","journal-title":"Radiol. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib118","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/annrheumdis-2012-203158","article-title":"EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis","volume":"72","author":"Colebatch","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2026.119869_bib119","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2026.119869_bib120","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/acsnano.8b08785","article-title":"Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite\/ceria co-decorated nanoparticles for rheumatoid arthritis treatment","volume":"13","author":"Kim","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119869_bib121","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.7150\/thno.33520","article-title":"Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone: an efficient therapeutic strategy against renal inflammation and fibrosis","volume":"9","author":"Tang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119869_bib122","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell\u2013targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib123","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2967\/jnumed.121.263774","article-title":"Total-Body 18F-FDG PET\/CT in autoimmune inflammatory arthritis at ultra-low dose: initial observations","volume":"63","author":"Abdelhafez","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1070445","article-title":"18F-FDG PET molecular imaging: a relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?","volume":"9","author":"Pean De Ponfilly \u2013 Sotier","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib125","doi-asserted-by":"crossref","DOI":"10.1186\/s41824-017-0022-y","article-title":"18F- FDG PET\/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab","volume":"2","author":"Fosse","year":"2018","journal-title":"Eur. J. Hybrid. Imaging"},{"key":"10.1016\/j.biopha.2026.119869_bib126","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.joca.2021.02.563","article-title":"Assessment of quantitative [18F]Sodium fluoride PET measures of knee subchondral bone perfusion and mineralization in osteoarthritic and healthy subjects","volume":"29","author":"Watkins","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.biopha.2026.119869_bib127","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0042-1760285","article-title":"Qualitative and quantitative evaluation of morpho-metabolic changes in bone cartilage complex of knee joint in osteoarthritis using simultaneous 18F-NaF PET\/MRI-a pilot study","volume":"33","author":"Jena","year":"2023","journal-title":"Indian. J. Radiol. Imaging"},{"key":"10.1016\/j.biopha.2026.119869_bib128","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2967\/jnumed.117.202200","article-title":"Translocator protein as an imaging marker of macrophage and stromal activation in rheumatoid arthritis pannus","volume":"59","author":"Narayan","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222844","article-title":"Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers","volume":"14","author":"Bruijnen","year":"2019","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.biopha.2026.119869_bib130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13550-019-0576-8","article-title":"Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI","volume":"91","author":"de Groot","year":"2019","journal-title":"EJNMMI Res. 2019"},{"issue":"14","key":"10.1016\/j.biopha.2026.119869_bib131","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13550-023-01064-4","article-title":"[68 Ga]Ga-FAPI-04 PET\/CT may be a predictor for early treatment response in rheumatoid arthritis","volume":"141","author":"Pan","year":"2024","journal-title":"EJNMMI Res. 2023"},{"key":"10.1016\/j.biopha.2026.119869_bib132","article-title":"Role and mechanism of fibroblast-activated protein-\u03b1 expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119869_bib133","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.1780390815","article-title":"Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis","volume":"39","author":"Chapman","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2026.119869_bib134","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.7150\/thno.102627","article-title":"Dual targeting heterodimer PET tracer [18F]AlF\u2011FAPI\u2011RGD in patients with rheumatoid arthritis: a pilot exploratory study","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119869_bib135","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1093\/rheumatology\/keae577","article-title":"68Ga-FAPI and 18F-NaF PET\/CT in psoriatic arthritis: a comparative study","volume":"64","author":"Yang","year":"2025","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.biopha.2026.119869_bib136","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1007\/s00330-025-11610-4","article-title":"Fibroblast activation imaging in rheumatoid arthritis: evaluating disease activity and treatment response using [18F]FAPI PET\/CT","volume":"35","author":"Mu","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.biopha.2026.119869_bib137","unstructured":"UCSF Arthritis Trial \u2192 Zr-89 Cimzia PET Imaging Rheumatoid Arthritis, (n.d.). https:\/\/clinicaltrials.ucsf.edu\/trial\/NCT03546335 (accessed July 21, 2026)."},{"key":"10.1016\/j.biopha.2026.119869_bib138","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2967\/jnumed.124.268717","article-title":"SUVs versus dynamic pharmacokinetic [18F]Fluoro-polyethylene glycol-folate uptake parameters in joints of rheumatoid arthritis patients at baseline and at 4 weeks of antitumor necrosis factor therapy","volume":"66","author":"van Binsbergen","year":"2025","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib139","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119869_bib140","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1016\/j.apsb.2025.09.039","article-title":"Artificial intelligence for radiopharmaceutical and molecular imaging","volume":"15","author":"Tao","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119869_bib141","article-title":"AI for imaging evaluation in rheumatology: applications of radiomics and computer vision\u2014current status, future prospects and potential challenges","volume":"9","author":"Xu","year":"2025","journal-title":"Rheumatol. Adv. Pract."},{"key":"10.1016\/j.biopha.2026.119869_bib142","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.122.265000","article-title":"Artificial intelligence for PET and SPECT image enhancement","volume":"65","author":"Balaji","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2024.1355912","article-title":"Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177Lutetium","volume":"4","author":"Ramonaheng","year":"2024","journal-title":"Front. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib144","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07612-5","article-title":"Critical review of partial volume correction methods in PET and SPECT imaging: benefits, pitfalls, challenges, and future outlook","volume":"53","author":"Azimi","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.biopha.2026.119869_bib145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.semnuclmed.2024.11.001","article-title":"Role of total body PET\/CT in inflammatory disorders","volume":"55","author":"Zoghi","year":"2025","journal-title":"Semin. Nucl. Med."},{"issue":"15","key":"10.1016\/j.biopha.2026.119869_bib146","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13550-025-01337-0","article-title":"Na[18F]F PET\/CT quantification in spondyloarthritis: comparative evaluation of SUV normalization approaches","volume":"151","author":"van der Heijden","year":"2025","journal-title":"EJNMMI Res. 2025"},{"key":"10.1016\/j.biopha.2026.119869_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2025.12.011","article-title":"Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: current applications, challenges, and future perspectives","volume":"16","author":"Shen","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119869_bib148","article-title":"Artificial intelligence and machine learning implemented drug delivery systems: a paradigm shift in the pharmaceutical industry","volume":"7","author":"Jena","year":"2024","journal-title":"J. Bio-X Res."},{"key":"10.1016\/j.biopha.2026.119869_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16101328","article-title":"Artificial Intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine","volume":"16","author":"Serrano","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119869_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104701","article-title":"AI-driven innovations in smart multifunctional nanocarriers for drug and gene delivery: a mini-review","volume":"210","author":"Noury","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2026.119869_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264825","article-title":"Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid)","volume":"17","author":"Heredia","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119869_bib152","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051364","article-title":"Controlled drug release from nanoengineered polysaccharides","volume":"15","author":"Bayer","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119869_bib153","first-page":"174","article-title":"Joints and needles: summary of radiosynoviorthesis","author":"Bie\u0144kowski","year":"2025","journal-title":"Reumatologia 63"},{"key":"10.1016\/j.biopha.2026.119869_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2019.01.002","article-title":"Radiosynovectomy in haemophilia","volume":"35","author":"Rodriguez-Merchan","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib155","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-021-00123-2","article-title":"Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals","volume":"6","author":"Gillings","year":"2021","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.biopha.2026.119869_bib156","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1007\/s00259-022-05738-4","article-title":"EANM guideline on quality risk management for radiopharmaceuticals","volume":"49","author":"Gillings","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.biopha.2026.119869_bib157","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-017-0025-9","article-title":"Guidance on validation and qualification of processes and operations involving radiopharmaceuticals","volume":"2","author":"Todde","year":"2017","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.biopha.2026.119869_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2022.990330","article-title":"Radiopharmaceutical good practices: Regulation between hospital and industry","volume":"2","author":"Faivre-Chauvet","year":"2022","journal-title":"Front. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib159","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-024-00318-3","article-title":"Novel radionuclides: demand, production and distribution for translational research in Europe","volume":"9","author":"Radzina","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.biopha.2026.119869_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114083","article-title":"Clinical translation of nanomedicines: challenges, opportunities, and keys","volume":"181","author":"Younis","year":"2022","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib161","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13346-022-01262-y","article-title":"Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes","volume":"13","author":"Dri","year":"2023","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2026.119869_bib162","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2026.119869_bib163","article-title":"The interactions between nanoparticles and the innate immune system from a nanotechnologist perspective","volume":"11","author":"Ernst","year":"2021","journal-title":"Nanomater. (Basel Switz."},{"key":"10.1016\/j.biopha.2026.119869_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114708","article-title":"Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles","volume":"194","author":"Kumar","year":"2023","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119869_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124843","article-title":"Cartilage-targeted drug nanocarriers for osteoarthritis therapy","volume":"666","author":"Morici","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119869_bib166","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/pharmaceutics17070912","article-title":"Nanoradiopharmaceuticals: design principles, radiolabeling strategies, and biomedicine applications","volume":"17","author":"N\u00fa\u00f1ez-Salinas","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119869_bib167","unstructured":"Quality Control in the Production of Radiopharmaceuticals | IAEA, (n.d.). https:\/\/www.iaea.org\/publications\/13422\/quality-control-in-the-production-of-radiopharmaceuticals (accessed July 21, 2026)."},{"key":"10.1016\/j.biopha.2026.119869_bib168","unstructured":"E. Medicines Agency, H. of Medicines Agencies, Radiopharmaceuticals - EU-IN Horizon Scanning Report, (2026). www.ema.europa.euwww.hma.eu (accessed July 30, 2026)."},{"key":"10.1016\/j.biopha.2026.119869_bib169","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00259-022-05785-x","article-title":"Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre","volume":"49","author":"Herrmann","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.biopha.2026.119869_bib170","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.2147\/IJN.S443168","article-title":"Long-term accumulation, biological effects and toxicity of BSA-coated gold nanoparticles in the mouse liver, spleen, and kidneys","volume":"19","author":"Jakic","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2026.119869_bib171","unstructured":"E. Medicines Agency - Heads of Medicines Agencies, Nanotechnology-based medicinal products for human use - EU-IN Horizon Scanning Report, (2025). www.ema.europa.euwww.hma.eu (accessed April 12, 2026)."},{"key":"10.1016\/j.biopha.2026.119869_bib172","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1053\/j.semnuclmed.2025.07.005","article-title":"Implementation of radiotheranostics: challenges, barriers, and IAEA-driven strategies for sustainable access","volume":"55","author":"Al-Ibraheem","year":"2025","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.biopha.2026.119869_bib173","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00259-025-07473-y","article-title":"Model-based cost-effectiveness studies in nuclear medicine: an unavoidable fact of life","volume":"53","author":"van Mossel","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:57:32Z","timestamp":1790081852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":173,"alternative-id":["S0753332226009054"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119869","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiolabeled drug-delivery and controlled-release nanocarriers for arthritis: Clinical evidence, kinetic modeling, radiation-safety challenges, and precision nanotheranostics","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119869"}}